Claims (4)
1. A method of treating a human mammalian subject suffering from graft versus host disease (GvHD) comprising administering to the human mammalian subject a therapeutically effective amount of at least one peptide selected from the group consisting of: (a) a peptide comprising the amino acid sequence of SEQ ID NO: 2, and (b) a peptide comprising the amino acid sequence of SEQ ID NO: 4.
Show 3 dependent claims
2. The method of claim 1 , wherein the at least one peptide is a peptide consisting of the amino acid sequence of SEQ ID NO:2.
3. The method of claim 1 , wherein the at least one peptide is a peptide consisting of the amino acid sequence of SEQ ID NO:4.
4. The method of claim 1 , wherein the route of administration of the peptide is intravascular injection, intraperitoneal injection, intramuscular injection, nasal administration or oral administration.
Full Description
No description text available for this patent.
Citations
This patent cites (3)
- US2012/0177645
- US90/07937
- USWO2004032867